Testing blood samples for early diagnosis of type 1 diabetes and celiac disease
Official title: Auto-antibody Dosage From Blood Spots for Diagnosis of Type 1 Diabetes and Celiace Disease
Run by Meyer Children's Hospital IRCCS · NCT06849622 · Data updated 2026-11-12
This study is testing if a new way of checking blood samples can help find type 1 diabetes and celiac disease earlier in children.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 2 Years to 13 Years |
| Sex | All |
| Enrollment | 1500 (estimated) |
| Sponsor | Meyer Children's Hospital IRCCS Academic / other |
| Locations | 1 site (Florence, Italy) |
| Status | Recruiting |
| Started | November 4, 2024 |
| Main results expected | March 30, 2026 |
| Study ends | March 30, 2026 |
| Registry record updated | February 27, 2025 |
| Trial ID | NCT06849622 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are children aged 2-13 years who either have a confirmed diagnosis of type 1 diabetes or celiac disease or are healthy controls without these conditions.
✕Probably not a fit
Patients outside the age range of 2-13 years or those with other unrelated health conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot study focuses on the early diagnosis of type 1 diabetes and celiac disease in children by screening for autoantibodies in blood samples. It aims to evaluate the concordance of results obtained from two different methods: dried blood spots on cards and traditional serum samples. The study will also assess the feasibility and acceptability of this screening approach among pediatricians and the local population in Tuscany. By identifying these conditions early, the study seeks to facilitate timely intervention and prevent severe complications.
Why it matters
Potential benefit: If successful, this study could lead to earlier diagnosis and treatment of type 1 diabetes and celiac disease in children, potentially reducing the risk of severe health complications.
How similar studies have gone: While this approach is innovative, similar studies have shown promise in early diagnosis of autoimmune conditions through blood screening methods.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged 2-13 years * Patients with a confirmed diagnosis of type 1 diabetes or celiac disease (positive controls) and children who do not have type 1 diabetes or celiac disease or autoantibodies associated with these pathologies (controls) * Obtained informed consent Exclusion Criteria: * none
Where it's running
-
Meyer Children's Hospital IRCCS
Florence, Italy, Italy Recruiting
Study contacts
- Study coordinator: Chiara Azzari
- Email: chiara.azzari@meyer.it
- Phone: +3905556621
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Nutrition and physical activity education for children with celiac disease
This study tests whether a combined nutrition and physical activity education program helps 8- to 12-year-olds with celiac disease improve body health, eating habits, activity, and quality of life while on a gluten-free diet.
-
Screening for lipid disorders in children and teens with chronic diseases to flag cardiovascular risk
This study tests a blood test and a questionnaire to screen children and teens with chronic conditions for lipid metabolism disorders and familial hyperlipidemia.
-
Sucrosomial iron for children with celiac disease and iron deficiency
This trial tests whether adding oral Sucrosomial® (Sideral forte®) iron drops to a gluten-free diet helps children aged 8–18 with newly diagnosed celiac disease and low iron or anemia recover hemoglobin and iron stores faster than diet alone.
-
Adherence to a Gluten-Free Diet and How it Relates to Thinking and Movement in Teens with Celiac Disease
This study tests whether following a gluten-free diet affects thinking speed, attention, memory, and motor skills in adolescents with celiac disease.
-
iLet Bionic Pancreas started through primary care for adults on insulin
This project will test whether starting the iLet Bionic Pancreas through primary care helps adults with insulin-treated type 1 or type 2 diabetes lower their A1c more than routine care over 13 weeks.
-
Evaluating a new insulin delivery system for children with newly diagnosed type 1 diabetes
This study is testing a new insulin delivery system to see if it helps children and teens with newly diagnosed type 1 diabetes manage their blood sugar better than traditional methods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.